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Most life scientists have relentlessly recommended any evaluative approach of agri-food
products to be based on examination of the phenotype, i.e. the actual characteristics of
the food, feed and fiber varieties: the effects of any new cultivar (or micro-organism,
animal) on our health are not dependent on the process(es), the techniques used
to obtain it.
The so-called “genetically modified organisms” (“GMOs”), on the other hand, are
commonly framed as a group with special properties – most frequently seen as
dubious, or even harmful.
Some social scientists still believe that considering the process is a correct background
for science-based understanding and regulation. To show that such an approach is
utterly wrong, and to invite scientists, teachers and science communicators to explain
this mistake to students, policy-makers and the public at large, we imagined a dialogue
between a social scientist, who has a positive opinion about a certain weight that
a process-based orientation should have in the risk assessment, and a few experts who
offer plenty of arguments against that view. The discussion focuses on new food safety.
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We are in a food analysis laboratory. The “prototype” of a new variety of sweet pepper
has just been put on the table. A few people are there: the lab manager, who is a
toxicologist; her assistant, an expert in food-related allergies and intolerance; an
agricultural biotechnologist from the philanthropic research unit where the cultivar
has been developed; an epistemologist of life sciences who specializes in agri-food
biotech regulation and policies. The last attendant is a professor of social sciences,
who heads a “Genetic Engineering and Society Center” at a university: since she is
convinced that it is necessary to “reboot the debate on genetic engineering”, their
discussion is very interesting.
The social scientist starts by affirming that “framing the debate around ‘product ver-
sus process’ is neither logical nor scientific” (her statements are quoted from Kuzma
2016, while the other speakers’ lines are imagined) because “from a scientific stand-
point, a product’s traits – harmful or otherwise – depend in part on the process by
which it is made. (This is especially evident from human gene-therapy trials, where
new methods for delivering genes have removed the need for potentially harmful viral
vectors.)” The epistemologist strongly disagrees, mentioning a useful categorization ofThe Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International
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vided, using colors as flags: “red” for biomedical-pharmaceutical applications, “green”
for agriculture, “white” for industrial, “grey” for environmental bioremediation. The
example given by the social scientist refers to the “red” domain, where this or that tech-
nique may be significant for a more or less risky outcome; in the “green” biotech world,
on the other hand, plants, animals and microorganisms are improved through methods
that can be very traditional, like crossing sexually compatible (sometimes even incom-
patible) varieties and species, or more recently invented, like physical or chemical
mutagenesis, or with direct intervention inside the genomes, either by inserting “donor”
DNA sequences (transgenesis) or not, through to the present day techniques of gene
editing, CRISPR-Cas9 being the latest exciting development (Hall 2016): each method,
or a mix of them, cannot be suspected in advance of being more or less problematic
and dangerous – or indeed safe. To assess an agri-food product’s risks and benefits, in
any imaginable sense, the process(es) which originated it is irrelevant.
The “green” biotechnologist goes on, kindly challenging the social scientist to provide
evidence that any technique, or group thereof, is inherently unsafe – or safe, for that
matter – underlining that no peer-reviewed paper has ever been published that shows
how a preemptive caution should be mandatory in any kind of agricultural biotech-
nology tinkering. However, since any process can result in unsatisfactory outcomes,
the only rational safety approach is to establish rules for evaluating each individual
product – the “archetype”, so to speak, of each new variety, to be later multiplied once
it has passed muster.
Yet, the lab director recalls that a few genetically engineered cultivars had proved to
be very harmful: a squash with toxic properties; a celery made resistant to certain
insects, which would bring out rashes in whoever handled it; a very toxic potato, com-
mercial name Lenape (Haslberger 2003, p. 739. Popular article on the Lenape: http://
boingboing.net/2013/03/25/the-case-of-the-poison-potato.html). The social scientist
quickly seizes her opportunity, underlining that such experiences show how certain
processes should be considered significant for stricter regulation! Timidly, the lab direc-
tor’s assistant says that no, those noxious cultivars were not “GMOs” but unfortunate
outcomes from traditional hybridization! With a touch of irony, the biotech expert asks
the sociologist whether she thinks that any older method should be strictly regulated,
since bad results may emerge… Noting the amused look of the lab director, the sociologist
realizes that they have played a little trick on her.
The researcher – this time seriously – points out that also quite a few genetically
engineered cultivars came out as unsatisfactory, even unsafe (Haslberger 2003, p. 740;
Kuiper et al. 2001, p. 516. See also other examples of “Discontinued Transgenic Products”:
http://cls.casa.colostate.edu/transgeniccrops/defunct.html): they were discarded, plain and
simple. It happens all the time: breeders, taking advantage of previous experiences
and accumulated knowledge, try and see, relying on competence and luck; that’s the
way science and technology work, even more so for “green” produce enhancements.
In agri-food labs, experimental greenhouses and open field plots, the waste bin is
never empty☹
As the epistemologist emphasizes, it is a basic empirical truth that even the smallest
change in the DNA of any organism – obtained via any method – may produce
massive phenotypic outcomes, most frequently not beneficial. That’s why life scientists
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not the process(es) used to create it, that must be evaluated on its own unique profile of
pros and cons related to health, environmental impact and commercial value. Many
position statements were issued by several scientific societies all around the world, says
the epistemologist; let’s just quote a petition signed by 3,400 scientists – inter alia 25
Nobel laureates: “The risks posed by foods are a function of the biological characteris-
tics of those foods and the specific genes that have been used, not of the processes
employed in their development.” (Prakash et al. 2000–2014). The same approach has been
affirmed with regard to the possible environmental risks of new cultivars: “genetically
engineered organisms should be evaluated and regulated according to their biological
properties (phenotypes), rather than the genetic techniques used to produce them.”
(Tiedje et al. 1989, p. 298). There is probably no other scientific field where the consensus
of experts is so overwhelming (Tagliabue 2016): also a few social scientists, who are too
often reluctant to admit such general agreement, should come to terms with it.
The actual process vs. product distinction, the lab director clarifies, relates to the fun-
damental ex-ante vs. ex-post approaches. Any risk analysis operations must follow the
standards established by the Codex Alimentarius (Codex Alimentarius 2016), which is
the international authority set up jointly by the Food and Agricultural Organization
(FAO) of the United Nations and the World Health Organization: such detailed criteria
dictate the approach to each new food product once a breeder submits it (ex-post) and
does not consider ex-ante the technique(s), the process(es) used during the experimental
manipulations. The new pepper variety that is sitting on the table in front of us may have
been derived from mutagenesis, either physical (irradiation) or chemical (exposure to cer-
tain substances that change the genome), or from RNA interference, having had some of
its traits modified without even changing the DNA structure; it may even come from
Mars. The technicians in charge of its safety assessment don’t know and don’t care: their
only focus must be on the actual properties of the submitted “prototypes”, following
adequate methods for their analyses.
That’s why, the epistemologist points out, the Codex ad hoc committee which was
established to write the guidelines for the safety assessment of foods derived from biotech-
nology (Codex Alimentarius Commission 2003–2008 and 2008) drew up the requested
documents, and then was dissolved. Of course, these instructions are a repetition of those
to be followed for the evaluation on any food, according to different risk profiles, because
there is no reason to think that “GMOs” should be treated differently. The committee did
its job properly, although it simply repeated that certain kinds of genetic engineering are
not in themselves riskier than others: a little waste of public money…
The social scientist is not convinced: “In their review procedures, the [regulatory]
agencies recognize that the process of engineering is important. The USDA, for
example, requires a “detailed description of the molecular biology of the system … used
to produce the regulated article”. The biotechnologist’s comment is sharp: while such
description may be very interesting for specialists, it has no relevance for the safety of
the outcome! Since we know very well that any kind of genotypic manipulation can
end up with problematic phenotypic outcomes, why doesn’t the regulator ask for
similar procedures in relation to any method of genetic manipulation or even for any
natural mutation? It would still be pointless, but at least coherent… The lab director
nods in approval.
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regulation. Indeed, it does not make sense scientifically to try to value one approach
more highly than the other.” You are both right and wrong, replies the epistemologist:
it is true that regulations often result in a (confused) mix of product and process; it is
false that both standpoints are similarly correct or useful. Please consider this again:
regulating the process implies the belief that some kinds of biotech operations must be
considered suspicious in advance – and, needless to say, the dubious products, as ill-
defined as they must be, are the so-called “genetically engineered organisms”. Such bias
is unscientific: “The main conclusion to be drawn from the efforts of more than 130
research projects, covering a period of more than 25 years of research, and involving
more than 500 independent research groups, is that biotechnology, and in particular
GMOs, are not per se more risky than e.g. conventional plant breeding technologies.”
(European Commission 2010, p. 16)
“Yet, the sociologist insists, many countries go further than the United States when it
comes to process-based triggers for regulation.” “International discussions have focused
on which types of gene-editing manipulation fall under regulatory definitions of GE
organisms”. The epistemologist now says that we must go back to our high-school
memories, recalling the myth of Procrustes: the ancient Greek rogue built a “bed”, i.e. a
template where he used to lay his victims, alternatively stretching them or cutting their
feet if they did not exactly fit his dogmatic measure. The same arbitrary approach has
been embraced by agri-food regulators almost everywhere in the world: they have
created a warped frame inside which they struggle to pigeon-hole the results of certain
processes (“GMOs!”) even before asking the question – the only rational one – whether
this or that product, individually considered, is more or less safe or unsafe. Their
ongoing embarrassment when new techniques emerge that cannot be placed inside, or
outside, their nonsensical rickety fence, is not surprising (Tagliabue 2015).
Plain and simple, says the biotech expert, law-makers have been replicating an
ongoing big mistake, because what we need is not groundless pre-emptive wariness in
regard to this or that “green” biotechnique (ex-ante), but accurate examination of each
“prototype” – such as our pepper on the table – once created and selected from many
unlucky outcomes (ex-post): if it is safe, hooray!, we will clone and propagate it in
millions of copies to be sold on the market; in many parts of the world, it will be
crossed with local varieties, well adapted to different climates and soils. Alas, not every
new cultivar will be available soon and everywhere, the lab director reminds us: if it is a
“GMO”, in many countries there will be lots of added controls, never-ending red tape,
legal hurdles, inflated costs or even straight prohibition. (McHughen 2016)
But the sociologist declares that even life scientists think that certain processes have
to be discussed regarding their possible sectoral regulation: “Ironically, the same GE
developers who once claimed that the process of GE does not matter for regulatory
purposes are now arguing that changes to the engineering process justify looser regula-
tory scrutiny.” That’s because, argues the epistemologist, these breeders are desperately
trying to evade the “GMO” semantic trap and the related regulatory thicket: a thorough
overhaul of the present legal background, in which a motley bunch of processes and
resulting products wear a scarlet letter, is very unlikely for the time being; therefore,
“green” biotechnologists are hoping that the new techniques will escape the nonsensical
added rules that have been overburdening an ill-defined pseudo-category of things!
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if all products (GE or otherwise) are to be treated the same, then either all products – GE
and conventionally bred – should be regulated, or neither should be. The first option is
impractical and the second inadvisable given that some products could be harmful.” What
do you mean “impractical”, asks the lab director: since we know that any new product,
independently of the process applied to create it, may be harmful, each new agricultural
invention should be evaluated on its own. Even if we manage to get rid of any pointless
preemptive regulation, the golden rule to be applied would remain the same, that is to
check out any new organism: this is not “inadvisable”, just the opposite! Instead, you know
what?, “GMOs” are over-scrutinized, while all the others are often not properly controlled.
For instance, the EFSA (European Food Safety Authority), i.e. the EU agency in charge of
scientific risk assessment, has a section which is explicitly dedicated to “GMOs”, with a
goodly number of scientists on the expert panel, detailed guidelines and precise instruc-
tions for breeders who want to submit an application for the authorization of a rDNA-
derived product (www.efsa.europa.eu/en/science/gmo); very similar new foods which are
obtained with slightly different biotech methods are completely exempt, and are not even
mentioned. Where’s the rationale for this?
If I may, the assistant chimes in, the approach aiming to regulate the “green” biotech
process(es), instead of the actual characteristics of each product, results in really bizarre
consequences: I can offer two examples, among many. 1. One of the most common
traits obtained via recombinant DNA is crop tolerance to herbicides: farmers find it
convenient to buy seeds of maize or soybean or other crops coupled to a weed-killer
substance that prevents weed growth but leaves the valuable plants intact. However,
there is another series of varieties of the same crops (some are for instance traded
under the commercial name Clearfield) that, similarly, have been made tolerant to pro-
prietary herbicides, and consequently are used together with them; but the desired trait
has been obtained through tissue culture and/or induced mutagenesis or selection of
natural mutants which are then crossed with other varieties and so – legalistically
speaking – without creating “GMOs”: consequently, the producer has legitimately and
happily avoided the very major barriers which it would have had to face if the technical
staff had directly pinched the DNA of the new varieties of wheat, rice, sunflower, lentil,
corn and canola (BASF 2017). Thus, similar cultivars made tolerant to weed killers
through direct genetic transfer (“GMOs”!) are subject to endless risk analyses, while for
other products, in which it has been possible to express an identical trait, by modifying
the genome in different yet targeted ways, the burdensome tests are not imposed. 2.
Even more curious is the case of the Amflora potato (VIB 2010, http://en.wikipe-
dia.org/wiki/Amflora). It was genetically engineered in order to inhibit the production
of one of the two kinds of starch which are typically present in the tuber. This modifi-
cation is useful for many industrial applications (e.g. the production of paper, which
absorbs a large share of potatoes) and avoids a costly and polluting process: the inacti-
vation of a certain gene solves the problem at source. The push and shove between the
European Commission, the ministers of various recalcitrant European states, and the
challenges of “anti-GMO” organisations concerning authorization of the new cultivar
lasted 17 years and eventually convinced the producer to give up marketing the product
in Europe (Laursen 2012), only to see insult added to injury: another German company
managed to produce the same desired phenotypic trait through a “non-GMO” method
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ticular bureaucratic burden (Fraunhofer-Gesellschaft 2009). No logic whatsoever in
regulating the processes instead of the product!
Generally speaking, the lab director continues, we can see again a confusion between
two very different concepts and related procedures: “ex-ante regulation” vs. “ex-post
controls”. In a rational world, preemptive regulation is intended to set the legal frame
with regard to harmful processes. Remember the “red” biotechnologies? When we are
dealing with infective viruses or lethal bacteria, we must be a priori very, very careful:
strict safety rules are a must, since any mistake in handling pathogens can have dire
consequences. In the “green” area, we perform the controls a posteriori, carefully
examining single products like this promising new pepper variety. Of course, that’s
the reason why in my lab nobody is wearing safety garments: we are testing eggplants
and harmless enzyme-producing bacteria, not vaccines.
This is why, the epistemologist adds, some images which are frequently shown as a
complement to articles regarding agri-food “GMOs” in the media are meaningless and
misleading: photos of people in maize fields with suits reminiscent of bacteriological
warfare are ludicrous – yet impressive (Clancy and Clancy 2016), quite effective in
terms of “anti-GMO” scaremongering.
Therefore, the new foods developer says to the sociologist, you have already drawn
the correct conclusion – which may be surprising for laypersons and quite a few social
scientists, not for geneticists, biologists and breeders: as far as agricultural products are
concerned, no special precautionary safety regulation is necessary for the processes,
while controls should be performed on each novelty (product), case by case, obviously
before starting mass production. Note again that the present situation is very unbalanced
almost everywhere: obsessive tests and redundant analyses are mandatory for “GMOs”,
almost no supervision is requested for the “prototypes” of all the other products.
I anticipate a possible objection, says the lab director: isn't it risky to rely on an ex-
post criterion of controls, given that some inadequate, or even harmful, trait can escape
scrutiny? Well, some risks may always exist. But, again, we must be aware that a higher
or lower level of possible unsafety is not related to the process(es) used to create new
cultivars: therefore, any ex-ante regulation of agri-food biotechnique(s) does not add
anything interesting or useful to the safety issue.
Thus, says the biotechnologist, reading quotes from an article written by the sociologist,
asking “what classes of GE products or processes should receive greater regulatory
scrutiny” is simply a groundless question if related to the agri-food area, and the
alleged “need to consider a mix of product and process issues to capture product
groups that are likely to be of greater concern” is utterly misplaced.
The sociologist poses another problem: “it is impossible to be completely ‘science
based’ in a regulatory system. Value judgments are embedded in all risk and safety
assessments. For example, the dose–response curve for a certain food additive might
be known, but such data do not by themselves tell regulators where to set an acceptable
safety limit.” There is a chilly moment: the lab director and the epistemologist stare at
each other. Please, colleague, the latter slowly says, be aware that you are confusing risk
assessment and risk management: the first is definitely a technical issue, the second is a
policy matter – although decisions (management) should be based on the best scientific
evidence available (assessment). This is a bedrock of the guidelines for risk analyses, as
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risk assessment and risk management, in order to ensure the scientific integrity of the
risk assessment, to avoid confusion over the functions to be performed by risk assessors
and risk managers and to reduce any conflict of interest.” (Codex Alimentarius 2016,
p. 125). We are not talking about watertight compartments, since the same basic text
establishes the prominence of risk managers in giving preliminary instructions on
how to conduct the risk assessment: “Risk assessment policy should be established by
risk managers in advance of risk assessment, in consultation with risk assessors and
all other interested parties.” (Codex Alimentarius 2016, p. 126). We all know that our
knowledge is still relative, sometimes poor: for example, the toxicity of asbestos was
undervalued for a long time! But the (scientific) assessment of the risks, even if necessarily
shaky or incomplete, is the starting point for deciding the (political) management of it:
how could it be otherwise?
In a seminal text (NAS-NRC 1983), the epistemologist points out, a clear indication
was given on keeping assessment and management separate, and the reason was the
frequent political interference in the scientific activity of the Environmental Protection
Agency in the previous years: this situation was criticized by many. Maybe the sociolo-
gists who have been insisting for several decades regarding the alleged blurry border
between risk assessment and management are obtaining the undesired effect of
encouraging the politicization of risk assessment? That would be ironic. I think it’s
time to reconsider the insistence of many social scientists on the near-impossibility of
neutrally scientific risk assessment guidelines, procedures and tests as a sort of intellectual
infatuation. In this sense, a more sober and sobering approach may be imagined, e.g. in
terms of a limited return to the “bureaucratic expertise model”. (Marchant 2012)
In labs like mine, adds the director, we are in charge of evaluation of new agricul-
tural products, as far as possible toxicity (www.fda.gov/food/guidanceregulation/gui-
dancedocumentsregulatoryinformation/ucm081825.htm) or allergenicity (USA: http://
www.jaad.org/article/S0190-9622(10)02126-2/abstract; UK: www.nice.org.uk/guidance
/CG116) effects are concerned: and let me tell you, although we are not omniscient, our
tools and procedures are “science-based”, while we follow the risk assessment policy as
established by risk managers.
In the meantime, the lab director’s assistant has put a couple of items on the table
and he now briefly explains what they are. 1. Seeds of Scuba rice, created at the Inter-
national Rice Research Institute in the Philippines, with the help of the University of
California at Davis: this innovative variety is good in the event of flooding, a frequent
occurrence with Asiatic monsoons; the seeds have been distributed to several millions
of small farmers, mostly in India. The gene which allows the new cereal to withstand
prolonged immersion was found in a landrace and transferred into high yielding modern
varieties; interestingly, the preliminary experiments designed to confirm that gene was the
correct one required the creation of a “GMO”: the DNA sequence was introduced by
transgenesis into the genome of a model variety of rice. Once the effectiveness of the gene
was confirmed, it was then moved by conventional crossing (Xu et al. 2006) accelerated
by Marker Assisted Selection. The non-transgenic method was chosen, despite being slow
and less precise, only to avoid wasting years with the bureaucratic nightmare which
oppresses “GMOs”. (Prof. Pamela Ronald, personal communication) 2. This small box,
the lab assistant continues, contains a variety of yeast made more efficient through the
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DNA sequences are inserted and then cancelled, once a satisfactory phenotype has
been obtained for subsequent multiplication: a product that leaves no traces of the
process! The safety – or otherwise – of the rice and the yeast, both organisms enhanced
through human ingenuity, that our lab has been requested to assess, has nothing, nothing
to do with the mix of methods concocted by the developers’ imagination.
Now the lab director shows a bottle of maize syrup: our technicians have fully examined
it, she says, the product is safe and nutritious. It contains no proteins, no DNA; even with
our advanced test tools, we cannot say whether it comes from transgenic cobs or other-
wise – the process. If somebody asks me whether it is a “GMO” or not, I will kindly reply
that such a question is meaningless – although the temptation would be to break the
bottle on their head…
The epistemologist looks the now impressed sociologist directly in the eye, saying:
if these examples do not delete in your mind the very notion of the supposed rele-
vancy of the process(es) to assess the qualities – or defects – of a product, we’ll be
very disappointed… ☹
Therefore, the biotech expert hopes to conclude, we don’t need to “reboot the
debate on genetic engineering”, starting once again on the wrong foot. All we need is
to follow a rational, science-based path, applying the necessary scrutiny to each and
every new agri-food product – “GMO” or otherwise – before its multiplication and
commercialization.
The epistemologist adds that if lawmakers wanted to reconsider the existing “green”
biotechnology regulations, which are almost always warped, a rational and science-
based technical-legal framework is already available (Conko et al. 2016); it is the result
of the participatory work of a number of scientists from several countries. The guide-
lines for careful assessment of new cultivars according to classes of gradual risk are
explained; to ascertain the pros and cons of each new plant, the different biotech
methods are considered irrelevant: the “GMO” blunder is not even mentioned! As for
field tests, sensible questions are asked, regarding the ecological impact (to what extent
is the plant potentially invasive?) and the health issues (what tests need to be performed
to evaluate possible allergenicity or toxicity?). Please note that we are talking about
assessing and listing the safety controls to be performed ex-post, i.e. when each agri-
food invention has been put on the lab table. The creators of these guidelines
emphasize that it is not a mere theoretical hypothesis, but it draws inspiration from
similar experiences which are already well tested in the real world: it is analogous to
existing regulatory regimes, such as those for quarantine regulations for plant or
animal pests. The approach is not fundamentally new and has worked well in practice
for decades.
Therefore, the biotechnologist declares with a slight but evident provocative tone, the
public should not be lured into a frequent delusion: the pressing problem is not the
relationship between “GMOs” and society, because this is a misleading approach.
The social scientist is now a little upset: should I shut down my “Genetic Engineering
and Society Center” then, she asks?! No ma’am, the epistemologist quietly replies, in
our humble opinion you should reassess the scope of your department, making it a
“Biotechnologies and Society Center”: this way, if you allow us, the narrow focus on the
botched “GMO” pseudo-category would be widened to a real societal big issue…
Tagliabue Life Sciences, Society and Policy  (2017) 13:3 Page 9 of 9P.S. – One year after, bad news: the delicious new pepper variety, as good and safe as
it was, has given unsatisfactory yield results, some 15–20% lower than its competitors
which are already on the market. At the research department, after a moment of
depression, breeders are ready to try again: one group of developers thinks that a
hybridization with an “heirloom” cultivar of pepper may be successful, adding better
organoleptic qualities to high productivity; another group imagines that inserting into
the pepper’s genome a certain DNA sequence taken from an orchid could do the trick.
Hopefully, in a few months they will show up again at the food analysis lab to assess
the safety of some new prototypes. There, technicians will perform the relevant tests
again, without even asking how the new product has been obtained: everybody knows
that the processes are irrelevant.
P.P.S. – This is just a fantasy, because the first outcome of the next experiment – the
hybridized cultivar – would be quickly examined, while the second approach would
create a “GMO” and therefore start a long, costly path.
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